Main page content

Advisory: Sublingual and Transmucosal Buprenorphine for Opioid Use Disorder: Review and Update

Cover of Publication

This advisory summarizes data on the use of sublingual and transmucosal buprenorphine for the medication-assisted treatment of opioid use disorder.

Publication ID
Publication Date

Units per Product



Advisory: Sublingual & Transmucosal Buprenorphine
File Type: PDF
File Size: 420 KB


Max Order Limit 10

You May Also Be Interested In